pharmaphorum

FEBRUARY 14, 2022

Seattle, US vaccine startup Curevo has raised $60 million in first-round financing that it says will be used to run head-to-head trials of its experimental shingles vaccines CRV-101 and GlaxoSmithKline’s market-leading Shingrix. 101’s immunogenicity and safety profile relative to Shingrix , according to Curevo.

Vaccines 52

Vaccines Immunization 52

Viseven

JULY 11, 2023

According to Fortune, Salesforce is the second most innovative company in the United States, followed by Alphabet. Throughout the years, Salesforce gained a reputation as a trusted advisor and partner among thousands of companies across the world’s fourteen largest industries, including life sciences and healthcare.

Health and Personal Care Stores 40

Health and Personal Care Stores Scheduling Appointments Communication Documentation 40

PharmaShots

JUNE 7, 2023

based on change from baseline on a standardized DAS28-CRP which evaluates the severity of RA using clinical and laboratory data Additionally, the company initiates PK study for AVT05 in Jan 2023. 60% vs 49%) with no deterioration in disease activity outcomes Disease duration (14 vs 3yrs.), 84% vs 64%) & 2yr. (60%

FDA 40

FDA Packaging Pharmaceutical Companies Pharmaceutical Companies 40